APA (7th ed.) Citation

Modi, S., Saura, C., Yamashita, T., Park, Y. H., Kim, S., Tamura, K., . . . Krop, I. (2020). Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer. The New England journal of medicine, 382(7), 610-621. https://doi.org/10.1056/NEJMoa1914510

Chicago Style (17th ed.) Citation

Modi, Shanu, et al. "Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer." The New England Journal of Medicine 382, no. 7 (2020): 610-621. https://doi.org/10.1056/NEJMoa1914510.

MLA (9th ed.) Citation

Modi, Shanu, et al. "Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer." The New England Journal of Medicine, vol. 382, no. 7, 2020, pp. 610-621, https://doi.org/10.1056/NEJMoa1914510.